Inventor · disambiguated record
Cosimo Dolente
Also filed as: DOLENTE COSIMO
25 granted patents·16 pending applications·23 citations·filing 2011–2025
93Inventor score
Top patents by PatentIndex Score
41 records- 0192US12344613B2EGFR inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Jul 1, 2025·3 cites·10 claims
- 0289US10414780B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 17, 2019·4 cites·2 claims
- 0387US10047102B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2015·Granted Aug 14, 2018·4 cites·16 claims
- 0483US10047081B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Aug 14, 2018·3 cites·25 claims
- 0583US2025066378A1Spiro-oxazolonesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0681US12486253B2Therapeutics for the degradation of mutant BRAFC4 THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·0 cites·4 claims
- 0781US10723729B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jul 28, 2020·1 cites·19 claims
- 0881US10399969B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Sep 3, 2019·2 cites·2 claims
- 0980US10246468B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Apr 2, 2019·3 cites·19 claims
- 1078US12162887B2Spiro-oxazolonesHOFFMANN LA ROCHE·Filed 2022·Granted Dec 10, 2024·0 cites·12 claims
- 1178US9540397B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jan 10, 2017·2 cites·24 claims
- 1278US2025289824A1Egfr inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1372US2022135571A1Therapeutic egfr inhibitorsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1471US12116349B2Methylquinazolinone derivativesHOFFMANN LA ROCHE·Filed 2022·Granted Oct 15, 2024·0 cites·54 claims
- 1570US11034687B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jun 15, 2021·0 cites·18 claims
- 1670US2024174621A1Methylquinazolinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1770US2024199581A1Therapeutics for the degradation of mutant brafC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1868US10829500B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2019·Granted Nov 10, 2020·0 cites·12 claims
- 1968US9920072B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Mar 20, 2018·1 cites·13 claims
- 2065US12479849B2EGFR inhibitors for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Nov 25, 2025·0 cites·8 claims
- 2165US2024010659A1New thiadiazolopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2265US2022112199A1Egfr inhibitor for medical useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2365US2024002407A1Thienopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2464US11578077B2Spiro-oxazolonesHOFFMANN LA ROCHE·Filed 2019·Granted Feb 14, 2023·0 cites·12 claims
- 2564US2024018163A1New thiazolopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2662US2023202990A1Cyclohexyl substituted triazolesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2762US2025179092A1Pyrido[1,2-a]pyrimidin-4-one derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2858US2022315591A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2958US2023322776A1New aryl-pyrido-pyrimidin-one derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3056US2022298145A1Braf inhibitors as paradox breakersHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3156US2024002390A1New indazole acetylene derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3254US2024018154A1New indazole derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3353US10696691B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jun 30, 2020·0 cites·6 claims
- 3445US9346824B2Cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes as V1a antagonistsHOFFMANN LA ROCHE·Filed 2014·Granted May 24, 2016·0 cites·8 claims
- 3540US8828989B2Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonistsDOLENTE COSIMO·Filed 2012·Granted Sep 9, 2014·0 cites·6 claims
- 3637US8461151B2Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenesDOLENTE COSIMO·Filed 2011·Granted Jun 11, 2013·0 cites·13 claims
- 3737US8420633B2Aryl-cyclohexyl-tetraazabenzo[e]azulenesDOLENTE COSIMO·Filed 2011·Granted Apr 16, 2013·0 cites·14 claims
- 3836US9828385B2Spiro-oxazolonesHOFFMANN LA ROCHE·Filed 2016·Granted Nov 28, 2017·0 cites·14 claims
- 3936US8513238B2Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenesDOLENTE COSIMO·Filed 2011·Granted Aug 20, 2013·0 cites·27 claims
- 4036US8492376B2Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenesDOLENTE COSIMO·Filed 2011·Granted Jul 23, 2013·0 cites·23 claims
- 4136US8481528B2Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenesDOLENTE COSIMO·Filed 2011·Granted Jul 9, 2013·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Cosimo Dolente files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →